$AMOD
ALPHA MODUS HOLDINGS, INC.

2023 Q1 Form 10-Q Financial Statement

#000119312523159821 Filed on June 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $580.0K $413.1K
YoY Change 40.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $630.0K $461.9K
YoY Change 36.4%
Operating Profit -$631.3K -$461.9K
YoY Change 36.68%
Interest Expense $1.710M $3.841M
YoY Change -55.48%
% of Operating Profit
Other Income/Expense, Net $1.943M $3.841M
YoY Change -49.42%
Pretax Income $1.312M $3.380M
YoY Change -61.19%
Income Tax $416.0K $0.00
% Of Pretax Income 31.71% 0.0%
Net Earnings $895.5K $3.379M
YoY Change -73.5%
Net Earnings / Revenue
Basic Earnings Per Share $0.04
Diluted Earnings Per Share $0.04 $112.7K
COMMON SHARES
Basic Shares Outstanding 5.484M
Diluted Shares Outstanding 5.484M

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K $569.4K
YoY Change -82.44%
Cash & Equivalents $1.300M $569.4K
Short-Term Investments
Other Short-Term Assets $1.500M $807.0K
YoY Change 85.87%
Inventory
Prepaid Expenses $212.5K
Receivables
Other Receivables
Total Short-Term Assets $1.561M $1.376M
YoY Change 13.41%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.20M $241.1M
YoY Change -87.89%
Other Assets
YoY Change
Total Long-Term Assets $29.21M $241.1M
YoY Change -87.89%
TOTAL ASSETS
Total Short-Term Assets $1.561M $1.376M
Total Long-Term Assets $29.21M $241.1M
Total Assets $30.77M $242.5M
YoY Change -87.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $151.0K $119.4K
YoY Change 26.52%
Accrued Expenses $257.0K $305.3K
YoY Change -15.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.659M $424.6K
YoY Change 290.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.000M $18.90M
YoY Change -62.96%
Total Long-Term Liabilities $7.000M $18.90M
YoY Change -62.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.659M $424.6K
Total Long-Term Liabilities $7.000M $18.90M
Total Liabilities $8.645M $19.32M
YoY Change -55.26%
SHAREHOLDERS EQUITY
Retained Earnings -$7.362M -$18.02M
YoY Change -59.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.347M -$18.02M
YoY Change
Total Liabilities & Shareholders Equity $30.77M $242.5M
YoY Change -87.31%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $895.5K $3.379M
YoY Change -73.5%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$289.7K -$223.5K
YoY Change 29.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $217.0M
YoY Change
Cash From Investing Activities $217.0M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $215.6M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -215.5M -85.00K
YoY Change 253454.57%
NET CHANGE
Cash From Operating Activities -289.7K -223.5K
Cash From Investing Activities 217.0M 0.000
Cash From Financing Activities -215.5M -85.00K
Net Change In Cash 1.177M -308.5K
YoY Change -481.47%
FREE CASH FLOW
Cash From Operating Activities -$289.7K -$223.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
506326
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Insight Acquisition Corp. /DE
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001862463
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40775
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3386030
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
333 East 91st Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10128
CY2023Q1 dei City Area Code
CityAreaCode
917
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
374-2922
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q1 us-gaap Cash
Cash
50931
CY2022Q4 us-gaap Cash
Cash
171583
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1297608
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
212500
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
367219
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1561039
CY2022Q4 us-gaap Assets Current
AssetsCurrent
538802
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
29211576
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
244314622
CY2023Q1 us-gaap Assets
Assets
30772615
CY2022Q4 us-gaap Assets
Assets
244853424
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
151013
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
128835
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
256993
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68216
CY2023Q1 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
160000
CY2022Q4 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
85000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1040836
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
467991
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
50000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
149041
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1658842
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
899083
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
156593
CY2023Q1 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
6600000
CY2022Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
260840
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
84890
CY2023Q1 inaq Forward Purchase Agreement Liability Non Current
ForwardPurchaseAgreementLiabilityNonCurrent
125473
CY2023Q1 us-gaap Liabilities
Liabilities
8645155
CY2022Q4 us-gaap Liabilities
Liabilities
13140566
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13631
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7361712
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11885332
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7347481
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30772615
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244853424
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
413077
CY2023Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
75000
CY2022Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
0
CY2023Q1 us-gaap Taxes Other
TaxesOther
50000
CY2022Q1 us-gaap Taxes Other
TaxesOther
48817
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-631326
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-461894
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
175950
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3899070
CY2023Q1 inaq Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability
GainLossChangeInFairValueOfForwardPurchaseAgreementLiability
-39104
CY2023Q1 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
-1884991
CY2022Q1 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
57679
CY2023Q1 inaq Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable
GainLossOnForgivenessOfDeferredUnderwritingFeesPayable
273110
CY2022Q1 inaq Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable
GainLossOnForgivenessOfDeferredUnderwritingFeesPayable
57679
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1943047
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3841391
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1311721
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3379497
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416252
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
895469
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3628151
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
100000
CY2023Q1 inaq Adjustment To Additional Paid In Capital Initial Value Of Forward Purchase Agreement
AdjustmentToAdditionalPaidInCapitalInitialValueOfForwardPurchaseAgreement
-86369
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
895469
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7347481
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18015079
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
895469
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
175950
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3899070
CY2023Q1 inaq Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability
GainLossChangeInFairValueOfForwardPurchaseAgreementLiability
-39104
CY2022Q1 inaq Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability
GainLossChangeInFairValueOfForwardPurchaseAgreementLiability
0
CY2023Q1 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
-1884991
CY2022Q1 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
57679
CY2023Q1 inaq Gain Loss On Elimination Of Deferred Underwriting Fee
GainLossOnEliminationOfDeferredUnderwritingFee
273110
CY2022Q1 inaq Gain Loss On Elimination Of Deferred Underwriting Fee
GainLossOnEliminationOfDeferredUnderwritingFee
0
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
156593
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-154719
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-69307
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
22178
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
85027
CY2023Q1 inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
188777
CY2022Q1 inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
30800
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
75000
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
572845
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2023Q1 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-99041
CY2022Q1 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
53231
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-289693
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-223529
CY2023Q1 inaq Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
1446649
CY2022Q1 inaq Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
0
CY2023Q1 inaq Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
215621388
CY2022Q1 inaq Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
0
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
80000
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
216988037
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
100000
CY2022Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
215621388
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-215521388
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1176956
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-308529
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171583
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877937
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348539
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
569408
CY2023Q1 us-gaap Cash
Cash
50931
CY2022Q1 us-gaap Cash
Cash
569408
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1297608
CY2023Q1 inaq Accretion For Class A Common Stock
AccretionForClassACommonStock
510
CY2022Q1 inaq Accretion For Class A Common Stock
AccretionForClassACommonStock
0
CY2023Q1 inaq Class B Converted To Class A On A One For One Basis
ClassBConvertedToClassAOnAOneForOneBasis
83369
CY2022Q1 inaq Class B Converted To Class A On A One For One Basis
ClassBConvertedToClassAOnAOneForOneBasis
0
CY2023Q1 inaq Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
-5126890
CY2022Q1 inaq Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
0
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-04-20
CY2021Q3 inaq Restrictedinvestmentsterm
Restrictedinvestmentsterm
P185D
CY2023Q1 us-gaap Share Price
SharePrice
10.05
CY2023Q1 inaq Percentage Of Common Stock Holding
PercentageOfCommonStockHolding
0.65
CY2023Q1 inaq Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
CY2023Q1 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023Q1 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q1 inaq Business Combination Date Of Consummation
BusinessCombinationDateOfConsummation
2023-05-07
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80000
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80000
CY2023Q1 inaq Business Combination Date Of Consummation
BusinessCombinationDateOfConsummation
2023-05-07
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80000
CY2023Q1 inaq Minimum Share Price Of The Residual Assets Remaining Available For Distribution
MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution
10.05
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1300000
CY2023Q1 inaq Working Capital Deficit
WorkingCapitalDeficit
59000
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2023Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
163000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
157000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation cover<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>ge limit of $250,000. <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. </div></div></div>
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div>
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
156593
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 inaq Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2848607
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
24000000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5484270
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5484270
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 inaq Waiver Of Underwriting Commissions
WaiverOfUnderwritingCommissions
5400000
CY2023Q1 inaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8400000
CY2023Q1 inaq Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable
GainLossOnForgivenessOfDeferredUnderwritingFeesPayable
273110
CY2023Q1 inaq Reminder Of Deferred Underwriting Commissions
ReminderOfDeferredUnderwritingCommissions
3000000
CY2023Q1 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
6600000
CY2022Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2023Q1 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001193125-23-159821-index-headers.html Edgar Link pending
0001193125-23-159821-index.html Edgar Link pending
0001193125-23-159821.txt Edgar Link pending
0001193125-23-159821-xbrl.zip Edgar Link pending
d174442d10q.htm Edgar Link pending
d174442dex311.htm Edgar Link pending
d174442d10q_htm.xml Edgar Link completed
d174442dex312.htm Edgar Link pending
d174442dex321.htm Edgar Link pending
d174442dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inaq-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
inaq-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
inaq-20230331_lab.xml Edgar Link unprocessable
inaq-20230331_def.xml Edgar Link unprocessable
inaq-20230331_pre.xml Edgar Link unprocessable